Benedetta Trevisan

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report.

Prolonged survival in a HER2 positive metastatic breast cancer patient with brain metastases treated with TDM1 after failure of next generation HER2 targeted therapies: case report.

Journal: Frontiers in oncology
Published: April 26, 2026

Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen.

Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen.

Journal: Frontiers in oncology
Published: October 27, 2025

Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.

Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.

Journal: European journal of nuclear medicine and molecular imaging
Published: September 11, 2025

Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases.

Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases.

Journal: Endocrine
Published: August 20, 2025

Quality of life questionnaire development and validation for adrenocortical carcinoma patients.

Quality of life questionnaire development and validation for adrenocortical carcinoma patients.

Journal: European journal of endocrinology
Published: April 29, 2025

Novel Therapeutic Options for Small Cell Lung Cancer.

Novel Therapeutic Options for Small Cell Lung Cancer.

Journal: Current oncology reports
Published: September 19, 2023

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.

Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.

Journal: Scientific reports
Published: April 06, 2023

Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.

Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.

Journal: Clinical lung cancer
Published: April 21, 2021

Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.

Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 18, 2020

Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.

Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.

Journal: Translational lung cancer research
Published: July 18, 2020

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.

Journal: Cancers
Published: November 04, 2019

DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.

DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.

Journal: Clinical lung cancer
Published: August 11, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026